Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Apr 1, 2025
BACKROUNDS: Multiple Sclerosis (MS) is a neurodegerative disease that is common worldwide, has no definitive cure yet, and negatively affects the individual's quality of life due to disease-related disability. Predicting disability in MS is difficult...
European journal of cancer (Oxford, England : 1990)
Apr 1, 2025
BACKGROUND: Breast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer death among women worldwide. Artificial intelligence (AI) shows promise for improving mammogram interpretation, especially in resource-limited sett...
OBJECTIVE: Identification of clinically meaningful subphenotypes of disease progression can enhance the understanding of disease heterogeneity and underlying pathophysiology. In this study, we propose a machine learning framework to identify subpheno...
Brain age gap, the difference between estimated brain age and chronological age via magnetic resonance imaging, has emerged as a pivotal biomarker in the detection of brain abnormalities. While deep learning is accurate in estimating brain age, the a...
BACKGROUND: Sarcopenia is associated with decreased survival in cervical cancer patients treated with radiotherapy. Cone-beam computed tomography (CBCT) was widely used in image-guided radiotherapy. Sarcopenia is assessed by the skeletal muscle index...
International journal of computer assisted radiology and surgery
Apr 1, 2025
PURPOSE: This study aimed to develop an artificial intelligence (AI) model for the surgical report output of laparoscopic lymph node dissection in the suprapancreatic region during gastric cancer surgery.
IMPORTANCE: The primary objective of any newly developed medical device using artificial intelligence (AI) is to ensure its safe and effective use in broader clinical practice.
IMPORTANCE: Retinopathy of prematurity (ROP) is the leading cause of preventable childhood blindness worldwide. If detected and treated early, ROP-associated blindness is preventable; however, identifying patients who might respond to treatment requi...
IMPORTANCE: Historically, fewer than 10% of adults with cancer have enrolled in clinical trials. Computational tools have been developed to match patients to trials, but these tools are relevant only when patients need new treatment.
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.